
Join to view full profile
1000 W Carson StC1 AnnexTorrance, CA 90502
Phone+1 310-222-2401
Fax+1 310-320-9688
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Sharon Adler, MD is a nephrologist in Torrance, California. She is currently licensed to practice medicine in California. She is a Professor of Medicine at UCLA.
Education & Training
Los Angeles County-Harbor-UCLA Medical CenterFellowship, Nephrology, 1981 - 1982
Loma Linda University Health Education ConsortiumResidency, Internal Medicine, 1977 - 1980
Zucker School of Medicine at Hofstra/NorthwellInternship, Internal Medicine, 1976 - 1977
State University of New York Downstate Medical Center College of MedicineClass of 1976
Certifications & Licensure
CA State Medical License 1977 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Nephrology
Publications & Presentations
PubMed
- 14 citationsPhase 1b/2a Study Assessing the Safety and Efficacy of Felzartamab in Anti-Phospholipase A2 Receptor Autoantibody-Positive Primary Membranous Nephropathy.Brad H Rovin, Pierre M Ronco, Jack F M Wetzels, Sharon G Adler, Isabelle Ayoub
Kidney International Reports. 2024-09-01 - 3 citationsFinerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD Trials.John M Flack, Rajiv Agarwal, Stefan D Anker, Bertram Pitt, Luis M Ruilope
Kidney Medicine. 2023-12-01 - Chronic interstitial nephritis in agricultural communities and pre-eclampsia: Is there a link?Carlos Orantes, Claudia Olano, Nehemias A Guevara, Carlos Salinas, Nehemias Guevara
Nefrologia. 2023-12-01
Press Mentions
The IgAN Treatment Pipeline: Pathogenesis ReviewApril 8th, 2025









